Drugs / plasma rich with WNV neutralizing antibodies
plasma rich with WNV neutralizing antibodies
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06590207 | Jul 2024 → Jan 2025 | West-Nile encephalitis | Sheba Medical Center | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | plasma rich with WNV neutralizing antibodies | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06590207 ↗ |
| Modality | Protein / enzyme biologic | “plasma rich in neutralizing antibodies” NCT06590207 ↗ |
| Route | Intravenous | “IV Convalescent Plasma vs. Saline” NCT06590207 ↗ |